Low Dose Bismuth Versus Lactobacillus Reuteri for H. Pylori Eradication

Summary

This study investigates the efficacy of a b.i.d. quadruple therapy containing Pylera® or L. reuteri for H. pylori infection.

Timeline

Start

2017-08-29

Primary completion

2018-11-29

Completion

2018-12-23

Outcome

Outcome not reported

Stopped: “Lactobacillus reuteri (Gastrus®) was not anymore available in the region”

Drugs

Indications